Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Solasia Announces Finance via Issuance of Warrant
Announcement on Capital Reduction, Surplus Appropriation (Deficit Disposition), and Election of Directors and Auditor
Solasia Announces Booking of Impairment Loss and Difference Between Fiscal 2024 Consolidated Earnings Forecast and Actual Results
Consolidated Financial Results for the Fiscal Year Ended December 31, 2024
Business Overview of Pipeline Products
Solasia Pharma, The Current Fiscal Year's Net Income to Narrow
Solasia Announces Change in Sales Partner for episil in China
Solasia Provides Notice of Revision to Its Fiscal 2024 Earnings Forecast
Solasia Pharma, Last Fiscal Year Net Income Loss to Narrow
Solasia Pharma, The Current Fiscal Year Net Income Loss Widened in Downward Revision
Solasia Provides Notice of Revision to Full-Year Earnings Forecast and Progress on Out-Licensing DARVIAS in China
Solasia Pharma K.K., July-September (3Q) Net Income Loss Narrows
Business Overview of Pipeline Products (Third Quarter of the Fiscal Year Ending December 31, 2024)
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending December 31, 2024 (under IFRS)
(Delay)Results of important non-clinical studies of SP-05
Solasia Announces Notice of Status of Progress in Out-licensing SP-02 (DARVIAS) in China